These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


76 related items for PubMed ID: 2389952

  • 21. [Intrapleural administration of pirarubicin in the treatment of malignant pleural effusion].
    Gotoh T, Nakamura T, Hiramori N, Fujii T, Fujita Y, Kida T, Arimoto T, Sakai M, Iwasaki Y, Tanaka Y.
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2121-7. PubMed ID: 1653558
    [Abstract] [Full Text] [Related]

  • 22. [Intrapleural administration of CDDP against malignant pleural effusions in breast cancer].
    Kikuchi K, Tsuyuki A, Fujishiro Y, Utsumi T, Fujisaki M, Kurihara E, Uematsu M.
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1905-8. PubMed ID: 2393307
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study.
    Bottomley A, Gaafar R, Manegold C, Burgers S, Coens C, Legrand C, Vincent M, Giaccone G, Van Meerbeeck J, EORTC Lung-Cancer Group, National Cancer Institute, Canada.
    J Clin Oncol; 2006 Mar 20; 24(9):1435-42. PubMed ID: 16446322
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment of malignant pleural effusion using vindesine and cisplatine intrapleurally injection (observation of 60 cases)].
    Zhang Z, Li D, Wu Z.
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jan 20; 24(1):29-31. PubMed ID: 11802935
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial.
    Guadagni S, Clementi M, Valenti M, Fiorentini G, Cantore M, Kanavos E, Amicucci G.
    In Vivo; 2006 Jan 20; 20(6A):715-8. PubMed ID: 17203752
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Intracavitary microspheres incorporating cisplatinum in the treatment of malignant effusions--clinical trials].
    Hagiwara A, Takahashi T, Yamaguchi T, Taniguchi H, Iwamoto A, Yoneyama C, Ito M, Sasabe T, Lee M, Wada R.
    Gan To Kagaku Ryoho; 1990 Aug 20; 17(8 Pt 2):1575-8. PubMed ID: 2389951
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.